alpha-fetoprotein peptide-pulsed autologous dendritic cell vaccine
Term · Oncology and biomedicine · MLC-T-ONC-009981
A cell-based cancer vaccine comprised of autologous dendritic cells pulsed with four alpha-fetoprotein (AFP) peptides, with potential immunostimulatory and antineoplastic activities. Upon administration, AFP peptide-pulsed autologous dendritic cell vaccine may stimulate anti-tumoral cytotoxic T lymphocyte (CTL) and antibody responses against AFP-expressing cancer cells, resulting in tumor cell lysis. AFP is overexpressed in a variety of cancer cells.
| Identifier | MLC-T-ONC-009981 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-009981",
"term": "alpha-fetoprotein peptide-pulsed autologous dendritic cell vaccine",
"field": "Oncology and biomedicine",
"definition": "A cell-based cancer vaccine comprised of autologous dendritic cells pulsed with four alpha-fetoprotein (AFP) peptides, with potential immunostimulatory and antineoplastic activities. Upon administration, AFP peptide-pulsed autologous dendritic cell vaccine may stimulate anti-tumoral cytotoxic T lymphocyte (CTL) and antibody responses against AFP-expressing cancer cells, resulting in tumor cell lysis. AFP is overexpressed in a variety of cancer cells.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/alpha-fetoprotein-peptide-pulsed-autologous-dendritic-cell-vaccine/"
}
Record 884 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.